Correlation Between SciVision Biotech and Feature Integration

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SciVision Biotech and Feature Integration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciVision Biotech and Feature Integration into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SciVision Biotech and Feature Integration Technology, you can compare the effects of market volatilities on SciVision Biotech and Feature Integration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciVision Biotech with a short position of Feature Integration. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciVision Biotech and Feature Integration.

Diversification Opportunities for SciVision Biotech and Feature Integration

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between SciVision and Feature is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding SciVision Biotech and Feature Integration Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Feature Integration and SciVision Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciVision Biotech are associated (or correlated) with Feature Integration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Feature Integration has no effect on the direction of SciVision Biotech i.e., SciVision Biotech and Feature Integration go up and down completely randomly.

Pair Corralation between SciVision Biotech and Feature Integration

Assuming the 90 days trading horizon SciVision Biotech is expected to generate 1.54 times more return on investment than Feature Integration. However, SciVision Biotech is 1.54 times more volatile than Feature Integration Technology. It trades about 0.2 of its potential returns per unit of risk. Feature Integration Technology is currently generating about 0.08 per unit of risk. If you would invest  11,250  in SciVision Biotech on November 7, 2024 and sell it today you would earn a total of  850.00  from holding SciVision Biotech or generate 7.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

SciVision Biotech  vs.  Feature Integration Technology

 Performance 
       Timeline  
SciVision Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, SciVision Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
Feature Integration 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Feature Integration Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

SciVision Biotech and Feature Integration Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SciVision Biotech and Feature Integration

The main advantage of trading using opposite SciVision Biotech and Feature Integration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciVision Biotech position performs unexpectedly, Feature Integration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Feature Integration will offset losses from the drop in Feature Integration's long position.
The idea behind SciVision Biotech and Feature Integration Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios